Finance

Beta
Lists
ONCOZ:STO
Oncozenge AB
SEK 6.32
-2.62%
(-0.17) 1D
Jun 5, 5:16:09 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCOZ...
Open
SEK 6.49
High
SEK 6.49
Low
SEK 6.32
Mkt. cap
88.78M
Avg. vol.
51.41K
Volume
14.97K
52-wk high
SEK 10.28
52-wk low
SEK 4.52
EPS
-SEK 1.82
Shares outstanding
14.05M
No. of employees
1
Open
SEK 6.49
High
SEK 6.49
Low
SEK 6.32
Mkt. cap
88.78M
Avg. vol.
51.41K
Volume
14.97K
52-wk high
SEK 10.28
52-wk low
SEK 4.52
EPS
-SEK 1.82
Shares outstanding
14.05M
No. of employees
1
News stories
From sources across the web
About Oncozenge AB
CEOPaul de Potocki
Employees1
Founded2020
Headquarters-
SectorPharmaceutical industry
Websiteoncozenge.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
117.00K
2.00K
1.00K
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.64M
3.48M
9.75M
6.80M
Operating expense
2.72M
3.48M
9.75M
6.80M
Total operating expenses
2.72M
3.48M
9.75M
6.80M
Operating income
-2.60M
-3.48M
-9.75M
-6.80M
Other non operating income
-
-
-
-
EBT including unusual items
-2.61M
-3.49M
-9.89M
-7.13M
EBT excluding unusual items
-2.61M
-3.49M
-9.89M
-7.13M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
85.00K
2.00K
-
2.00K
Net income
-2.61M
-3.49M
-9.89M
-7.13M
Net profit margin
-2,228.21%
-174,550.00%
-988,600.00%
-
Earnings per share
-
-
-
-
Interest and investment income
-
1.00K
15.00K
-
Interest expense
-2.00K
-13.00K
-154.00K
-330.00K
Net interest expenses
-2.00K
-12.00K
-139.00K
-330.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer